Cilengitide: does it really represent a new targeted therapy for recurrent glioblastoma?
Chamberlain
Marc C
MC
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005909:Glioblastoma / Q000188:drug therapy*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D012910:Snake Venoms / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D012910:Snake Venoms; C422910:Cilengitide